University of Minnesota. Driven to Discover.
Peramivir, made by BioCryst, is intended to be given to influenza patients in a single intravenous dose.
The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.
The multipronged attack includes an executive order, a national strategy, and a detailed PCAST report.
The bill provides increases for the CDC, DHS, and FDA and funds for pandemic readiness.
Sort Results By:
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyAcademic Health Center, University of Minnesota, Minneapolis, MN
© 2018 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.